Dataset Information


Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu?).

ABSTRACT: Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGlu5) represent a promising therapeutic strategy for the treatment of schizophrenia. Starting from an acetylene-based lead from high throughput screening, an evolved bicyclic dihydronaphthyridinone was identified. We describe further refinements leading to both dihydronaphthyridinone and tetrahydronaphthyridine mGlu5 PAMs containing an alkoxy-based linkage as an acetylene replacement. Exploration of several structural features including western pyridine ring isomers, positional amides, linker connectivity/position, and combinations thereof, reveal that these bicyclic modulators generally exhibit steep SAR and within specific subseries display a propensity for pharmacological mode switching at mGlu5 as well as antagonist activity at mGlu3. Structure-activity relationships within a dihydronaphthyridinone subseries uncovered 12c (VU0405372), a selective mGlu5 PAM with good in vitro potency, low glutamate fold-shift, acceptable DMPK properties, and in vivo efficacy in an amphetamine-based model of psychosis.

SUBMITTER: Turlington M 

PROVIDER: S-EPMC4096224 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3572342 | BioStudies
2013-01-01 | S-EPMC3908770 | BioStudies
2013-01-01 | S-EPMC3629835 | BioStudies
1000-01-01 | S-EPMC3876804 | BioStudies
2015-01-01 | S-EPMC4634704 | BioStudies
2015-01-01 | S-EPMC4443790 | BioStudies
2019-01-01 | S-EPMC6286225 | BioStudies
2013-01-01 | S-EPMC3807069 | BioStudies
1000-01-01 | S-EPMC3608436 | BioStudies
2019-01-01 | S-EPMC7088891 | BioStudies